| Linagliptin Bests Glimepiride in Reducing CV Risk - Medscape |
|
|
Medscape It is metabolized by the liver, "so you can give this to patients with renal impairment without dose adjustment." "The cardiovascular benefit of linagliptin is also very important in the setting of diabetes," Dr. Gallwitz said. ... New data for linagliptin* to be presented at the ADA Canada NewsWire (press release) New data for linagliptin* show clinically meaningful efficacy similar to |